This protocol combines in situ hybridization with immunofluorescence to identify olfactory and vomeronasal receptor genes expressed in olfactory sensory neurons after activation by chemical stimuli in the mouse.
Animals rely on chemical communication to convey and perceive relevant environmental information, ranging from assessment of food quality to detection of available mating partners or threats. In mice, this task is executed primarily by the olfactory system and its underlying subsystems, including the main and accessory olfactory systems. Both have peripheral organs populated by sensory neurons expressing G-protein coupled receptors able to bind chemical cues that reach the nasal cavity. Even though the molecular characteristics of these receptors is well understood, little is known about their cognate specific ligands. The method described here combines in situ hybridization detection of olfactory or vomeronasal receptors with immunodetection of phosphorylated ribosomal protein S6 (pS6) – a marker of neuronal activation. This protocol was devised to identify neurons activated after a single event of exposure to purified or complex chemical stimuli detected by the olfactory organs. Importantly, this technique allows the investigation of neurons triggered in biologically relevant contexts. Ideally, this method should be used to probe the molecular biology of the olfactory system and to study olfactory behaviors.
Chemosignaling is the most widespread form of communication in animals. In mammals, detection of chemical cues is mediated mainly through olfaction and is paramount for finding food, locating possible mating partners, and avoiding potential predators1,2,3. The mouse olfactory system is further divided into different subsystems, each with their own anatomical, physiological and molecular properties4. Among these, the main olfactory system (MOS) and accessory olfactory system (AOS) are the most widely studied and better characterized.
The MOS is mostly responsible for the detection of volatile chemical molecules that reach the nasal cavity. This is accomplished by olfactory sensory neurons (OSNs), which populate the system's sensory interface – the main olfactory epithelium (MOE). Each OSN expresses one out of thousands of olfactory receptors (ORs) in a monogenic and monoallelic fashion5. Furthermore, ORs tend to be broadly tuned6, and a single odorant may bind to more than one OR, generating a combinatorial code for odors7.
In turn, the AOS is mainly responsible for pheromone and kairomone detection. These ligands activate vomeronasal sensory neuros (VSNs) in the vomeronasal organ (VNO). VSNs in the apical zone of the VNO express receptors from the vomeronasal receptor 1 family (V1Rs)8, while neurons in the basal zone express the vomeronasal receptor 2 family (V2Rs)9. Importantly, it has been shown that some VSNs co-express more than one vomeronasal receptor10,11,12.
Despite all available information on the molecular characteristics of ORs and VRs, knowledge on their cognate ligands is still very limited. The identification of specific olfactory neurons responsible for the detection of a molecule or complex stimulus is an important task for those investigating olfaction, olfactory-driven behaviors, and physiological responses. Several strategies have been attempted to deorphanize olfactory receptors, including calcium-imaging7, single-cell RNA sequencing13,14, heterologous receptor expression15, and strategies based on immediate early genes (IEGs)16. More recently, some techniques have been employed to assess the modulatory effects of odorants in sensory neurons, using in vivo calcium imaging17,18 and fluorescent-protein tagged single-cell RNA sequencing strategies19. Most of these techniques demand an artificial setup or are performed on dissociated neurons, making it impossible to simultaneously assess behaviors triggered by the odors used.
The protocol described here allows the identification of sensory neurons activated after a single event of odor exposure, by combining riboprobes that detect specific ORs or VRs with the immunodetection of phosphorylated S6 ribosomal protein (pS6), a proxy for neuronal activation. This method is a reliable way to investigate the identity of sensory neurons activated by different chemosignals in a biologically relevant context.
Animal procedures were carried out in accordance with Animal Protocol #1883-1, approved by the University of Campinas (Institute of Biology's Institutional Animal Care and Use Committee – Committee for Ethics in Animal Use in Research), which follows the guidelines established by the federal National Council for Animal Experimentation Control (CONCEA).
1. Material preparation
2. Riboprobe synthesis
NOTE: The following procedure to synthesize 1 kb digoxigenin-labeled cRNA probes for in situ hybridization via in vitro transcription is based on previously published protocols20,21,22,23.
3. Exposure of mice to olfactory stimuli
4. Tissue dissection and freezing
5. Step-by-step in situ hybridization protocol
6. pS6 immunostaining
7. Microscopy imaging
The current protocol aims at obtaining microscopy images in which the experimenter's gene of interest and the neuronal activity marker pS6 are fluorescently labeled. The described method involves Tyramide Signal Amplification, which produces clear and strong labeling with little to no background. pS6 immunostaining appears as cytoplasmic fluorescent signal that usually fills the entire neuronal cell body, whereas in situ hybridization signal for olfactory receptor neurons shows as cytoplasmic staining. pS6 is a transient marker of olfactory neuron activation and therefore the associated immunostaining signal will appear stronger in cells that have been activated in the 1 h period preceding sensory organ fixation. Fluorescence crosstalk between staining for pS6 and receptors is not expected, provided the appropriate bandpass microscopy filters are used.
Labeled sections can be used to evaluate co-localization between the two types of staining, allowing for the identification of genes expressed by the population of activated neurons under study. Figure 2A,B shows VNO images from a mouse exposed to cat odor, with co-localization of signals for V2R receptors in clade A4 and for pS6, indicating that neurons expressing those olfactory receptors are activated by the stimulus used. Conversely, when activated neurons do not express the olfactory receptors under scrutiny, no co-localization between signals is expected (Figure 2C,D).
Challenges inherent to this protocol include maintaining the integrity of cryostat sections, particularly because the olfactory organs are dissected without fixation. This may result in torn sections (Figure 3A) or partially deformed or curled sections during subsequent incubations (Figure 3B). Another potential problem is high fluorescence background staining, possibly derived from insufficient blocking or excessive signal development in amplification steps, in both pS6 immunohistochemistry (Figure 3C) or in situ hybridization steps (Figure 3D).
Figure 1. Schematic representation showing vertical placement of the VNOs inside the embedding medium to obtain transversal cryostat sections. (A) Use of a syringe to place the VNOs inside the histology mold, with the bone shell facing sideways. (B) Instructions for trimming the specimen block and attaching it to the cryostat holder (grey). Please click here to view a larger version of this figure.
Figure 2. Representative images of dual in situ hybridization/pS6 immunohistochemistry staining of VNOs after mouse exposure to cat odors. (A) Microscopy image after in situ hybridization using riboprobes for V2R receptors in clade A4 (green fluorescence) and pS6 immunostaining (red). Middle panel: overlay of dual staining and nuclear counterstaining (blue). Arrowheads indicate co-localization of in situ hybridization and pS6 immunohistochemistry signals. (B) High magnification images from different VNO sections subjected to dual staining in A. (C) Microscopy image after in situ hybridization using probes for V2R receptors in clade A8 (green fluorescence) and pS6 immunohistochemistry (red). Middle panel: overlay of dual staining and nuclear counterstaining (blue). (D) High magnification images from different VNO sections subjected to the same dual staining as in C. Scale bars are 100 μm. Please click here to view a larger version of this figure.
Figure 3. Representative suboptimal results. (A) Damaged, teared VNO (arrow). (B) Curled VNO section (arrow). (C) High background in pS6 immunostaining signal. Arrow shows an example of border effect. (D) High background staining after riboprobe in situ detection. Arrowheads indicate true staining. Scale bars are 100 μm. Please click here to view a larger version of this figure.
Problem | Possible causes | Proposed solution |
Tears in sections or difficulty when sectioning | Bones are impairing sectioning process | Replace cryostat blade or change cryostat block orientation until section quality improves. Usually, the remaining bones, if present, are positioned opposite to the side where the cryostat blade first hits the specimen. |
Loss of sections during staining | Use of non-adhesive microscope slides | Use silanized or other type of positively-charged slides. Consider changing brands. |
Harsh conditions in situ hyb steps | Handle slides carefully during staining washes, especially when inserting and removing from wash solutions and during coverslip displacement. | |
Low in situ hybridization signal | Insufficient probe hybridization | Increase probe concentration. Reduce hybridization or probe wash temperature. |
Poor tyramide signal ampification | Extend duration of tyramide amplification steps. | |
High staining background | Insufficient blocking | Check blocking solution concentration or extend blocking duration. |
Excessive tyramide signal ampification | Reduce duration of tyramide amplification steps. | |
Sections drying up during staining | Maintain sections covered in solution at all times. Minimize time between washes, during which slides are outside the staining jars and may dry up. |
Table 1. Troubleshooting table with the most frequent problems and proposed solutions. This table presents steps to troubleshoot the protocol, in cases where tears are found in sections or when there is difficulty sectioning. Other problems are also addressed, such as loss of sections during staining, low in situ hybridization signal, and high staining background.
The protocol described here reliably identifies sensory neurons activated by chemical cues in the olfactory system through a combination of in situ detection of OR or VR receptors with immunodetection of pS6, an indirect marker of neuronal activity. The experimenter must take extra caution to maintain histology integrity and perform all steps before hybridization under RNase-free conditions. Failure to do so may cause mRNA degradation and compromise riboprobe labeling. Care must be exercised during dissection of the olfactory organs, as unfixed tissue is particularly fragile and may be easily damaged.
In situ hybridization in this protocol involves two rounds of signal amplification, and it must be noted that fluorescence intensity may be affected by factors related to hybridization or signal development. For example, incubation temperatures and periods must be empirically optimized. Weak labeling may be due to low probe concentration, high hybridization temperature, or short tyramide labeling. Conversely, high background may be due to low hybridization temperature or over-development in tyramide incubation steps. These parameters must be adjusted to attain optimal signal-to-background ratio (see Table 1 for a thorough troubleshooting discussion).
Similarly, pS6 immunodetection may lead to low fluorescence intensity or high background staining. These problems generally arise from inadequate duration of tyramide incubation steps, insufficient blocking, or inadequate quenching of endogenous peroxidases (Table 1).
Despite such methodological concerns, the procedure described here has important advantages. pS6 immunodetection is simpler and faster than double in situ hybridization with riboprobes designed to target popular IEGs, such as c-fos, Arc, and Egr-1. The method described here generally produces very clear labeling in olfactory sensory neurons23,25,26. Furthermore, the technique allows the identification of activated neurons in biologically relevant contexts (i.e., upon the detection of odors from a potential mating partner or from a predator), in experimental paradigms where behaviors can be simultaneously assessed and recorded. Other types of investigation aiming to detect olfactory neuron activation do not share this advantage, as they employ artificial settings in which the animal is head-fixed or euthanized prior to neural recordings or calcium imaging. The ability to identify neurons activated by specific chemical cues in freely moving mice is a powerful asset in several research areas, ranging from those studying the molecular biology of the olfactory system and chemical ecology to those interested in behavioral neuroscience and ethology. This protocol provides a reliable method for the investigation of chemodetection in these studies.
The authors have nothing to disclose.
We thank GAG Pereira and JA Yunes for resources, APF Ferreira and WO Bragança for administrative and technical help, and the Life Sciences Core Facility (LaCTAD-UNICAMP) staff for help with confocal microscopy. This work was supported by the Sao Paulo Research Foundation (FAPESP; grant numbers 2009/00473-0 and 2015/50371-0 to F.P.), by PRP/UNICAMP (grant numbers 2969/16, 725/15, 348/14, and 315/12 to F.P.), by FAPESP fellowships to V.M.A.C. (2014/25594-3, 2012/21786-0, 2012/01689-0), T.S.N. (2012/04026-1), and by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) fellowship to T.S.N.
10x phosphate-buffered saline (PBS) | Thermo Fisher Scientific | AM9625 | n/a |
20x amplification diluent (reaction buffer from Alexa Fluor 555 Tyramide SuperBoost kit) | Thermo Fisher Scientific | B40923 or B40922 | refered to as Amplification Buffer A in working solutions for tyramide-Alexa 488 or tyramide-Alexa 555 signal amplification |
20x SSC | Merck (Calbiochem) | 8310-OP | n/a |
30% Bovine Serum Albumin (BSA) | Merck (Sigma-Aldrich) | A9576 | n/a |
30% hydrogen peroxyde (H2O2) | Merck (Sigma-Aldrich) | H1009 | n/a |
Acetic anhydride | Merck (Sigma-Aldrich) | 320102 | n/a |
Agarose | Merck (Sigma-Aldrich) | A9539 | n/a |
Amplification diluent (from TSA Biotin kit) | Akoya Biosciences (Perkin Elmer) | SAT700001EA | refered to as Amplification Buffer B in working solution for tyramide-biotin signal amplification |
Anti-pS6 (Ser 244/247) rabbit polyclonal antibody | Thermo Fisher Scientific | Cat# 44-923G, RRID:AB_2533798 | n/a |
Blocking buffer 1x (from Alexa Fluor 488 Tyramide SuperBoost kit) | Thermo Fisher Scientific | B40923 or B40922 | refered to as blocking solution B in the tyramide signal development step |
Blocking reagent (from TSA Biotin kit) | Akoya Biosciences (Perkin Elmer) | SAT700001EA | refered to as blocking reagent A in the formulation for TNB buffer |
DAPI nuclear stain | Thermo Fisher Scientific | D1306 | n/a |
Denhardt's solution (50x) | Merck (Sigma-Aldrich) | D9905 | n/a |
Deoinized formamide | Merck (Sigma-Aldrich) | F9037 | n/a |
Dextran sulfate solution (50%) | Merck (Chemicon) | S4030 | n/a |
Ethylene-diamine-tetraacetic acid (EDTA) | Merck (Sigma-Aldrich) | E9884 | n/a |
Hoechst 33342 nuclear stain | Thermo Fisher Scientific | H1399 | n/a |
Hydrochloric acid (HCl) | Merck (Sigma-Aldrich) | 320331 | n/a |
Olfactory stimuli | n/a | Papes et al. (2010), Carvalho et al. (2015), Nakahara er al. (2016), Carvalho et al. (2020) | n/a |
Paraformaldehyde | Merck (Sigma-Aldrich) | P6148 | n/a |
Peroxidase-conjugated anti-digoxigenin antibody (Fab fragments) | Merck (Roche) | 11207733910; RRID:AB_514500 | refered to as peroxidase-conjugated anti-DIG antibody |
Peroxidase-conjugated anti-rabbit secondary antibody (polyHRP-conjugated goat anti-rabbit reagent from Alexa Fluor 488 Tyramide SuperBoost kit) | Thermo Fisher Scientific | B40922 | n/a |
Peroxidase-conjugated streptavidin (from TSA biotin kit) | Akoya Biosciences (Perkin Elmer) | SAT700001EA | n/a |
ProLong Gold antifade mountant | Thermo Fisher Scientific | P36934 | refered to as anti-fading mounting medium |
RNase-free ultrapure water | Thermo Fisher Scientific | 10977015 | n/a |
Sodium chloride (NaCl) | Merck (Sigma-Aldrich) | S9888 | n/a |
Sodium dodecyl sulfate (SDS) | Merck (Sigma-Aldrich) | 436143 | n/a |
Sodium hydroxide (NaOH) | Merck (Sigma-Aldrich) | S8045 | n/a |
Sucrose | Merck (Sigma-Aldrich) | S0389 | n/a |
Triethanolamine | Merck (Sigma-Aldrich) | T58300 | n/a |
Triton X-100 | Merck (Sigma-Aldrich) | X100 | n/a |
Trizma hydrochloride (Tris-Cl) | Merck (Sigma-Aldrich) | T5941 | n/a |
Tween-20 | Merck (Sigma-Aldrich) | 822184 | n/a |
Tyramide-Alexa 488 conjugate (from Alexa Fluor 488 Tyramide SuperBoost kit) | Thermo Fisher Scientific | B40922 | n/a |
Tyramide-Alexa 555 conjugate (from Alexa Fluor 555 Tyramide SuperBoost kit) | Thermo Fisher Scientific | B40923 | n/a |
Tyramide-Biotin conjugate (from TSA Biotin kit) | Akoya Biosciences (Perkin Elmer) | SAT700001EA | n/a |
Yeast tRNA | Merck (Roche) | 10109495001 | n/a |
Critical Commercial Assays and Animals | |||
Alexa Fluor 488 Tyramide SuperBoost kit | Thermo Fisher Scientific | B40922 | n/a |
Alexa Fluor 555 Tyramide SuperBoost kit | Thermo Fisher Scientific | B40923 | n/a |
DIG RNA Labeling Kit (SP6/T7) | Merck (Roche) | 11175025910 | n/a |
High Sensitivity RNA ScreenTape Analysis reagents (buffer, ladder, and tape) | Agilent | 5067-5580, 5067-5581, and 5067-5579 | refered to as automated electrophoresis system |
Mouse: C57BL/6J inbred strain | Jackson Laboratories | Stock No: 000664; RRID:IMSR_JAX:000664) | n/a |
ProbeQuant G-50 Micro Columns | Cytiva Biosciences | 28903408 | refered to as gel filtration-based purification kit |
QIAquick gel extraction kit | Qiagen | 28506 | refered to as mini column-based gel-purification kit |
RNeasy MinElute cleanup kit | Qiagen | 74204 | refered to as mini column-based RNA purification kit |
TSA Biotin kit | Akoya Biosciences (Perkin Elmer) | SAT700001EA | n/a |
Oligonucleotides | |||
5’ – AAACTTCATCCTTACAGAATGG CAG – 3’ |
Integrated DNA Technologies | n/a | Olfr692 |
5’ – ACTGGCTTTGGGACAGTGTGAC – 3’ | Integrated DNA Technologies | n/a | |
5’- GGTAATATCTCCATTATCCTAGTT TCCC – 3’ |
Integrated DNA Technologies | n/a | Olfr124 |
5’ – TTGACCCAAAACTCCTTTGTTAG TG – 3’ |
Integrated DNA Technologies | n/a | |
5’ – ATGGGAGCTCTAAATCAAACAA GAG – 3’ |
Integrated DNA Technologies | n/a | Olfr1509 |
5’ – TAGAAAACCGATACCACCTTGTC G – 3’ |
Integrated DNA Technologies | n/a | |
5’ – TACATCCTGACTCAGCTGGGGA ACG – 3’ |
Integrated DNA Technologies | n/a | Olfr1512 |
5’ – GGGCACATAGTACACAGTAACA ATAGTC – 3’ |
Integrated DNA Technologies | n/a | |
5’ – GAGGAAGCTCACTTTTGGTTTG G – 3’ |
Integrated DNA Technologies | n/a | Olfr78 |
5’ – CAGCTTCAATGTCCTTGTCACA G – 3’ |
Integrated DNA Technologies | n/a | |
5’ – TGGGTTGGAGGCTTATCATACC TG – 3’ |
Integrated DNA Technologies | n/a | Olfr691 |
5’ – AAGAACAACACAGAGTCTTGAT GTC – 3’ |
Integrated DNA Technologies | n/a | |
5’ – AGAAGTAACTAACACCACTCAT GGC – 3’ |
Integrated DNA Technologies | n/a | Olfr638 |
5’ – TTAGTGCACCTTTCTTTGCAAC – 3’ | Integrated DNA Technologies | n/a | |
5’ – TAACAGCTCTTCCCATCCCCTG TTC – 3’ |
Integrated DNA Technologies | n/a | Olfr569 |
5’ – TAGGGTTGAGCATGGGAGGAAC AAGC – 3’ |
Integrated DNA Technologies | n/a | |
5’ – CACTGGATCAACTCTAGCAGCA CTG – 3’ |
Integrated DNA Technologies | n/a | Vmn2r1 |
5’ – CTGCCCTTCTTGACATCTGCTG AG – 3’ |
Integrated DNA Technologies | n/a | |
5’ – ATCGGATCCACTGCTTTAGCATT TCTTACAGGACAG – 3’ |
Integrated DNA Technologies | n/a | Vmn2r2 |
5’ – ATCCTCGAGTCATGCCTCTCCAT AAGCAAGGAATTCCAC – 3' |
Integrated DNA Technologies | n/a | |
5’ – TAGGAAGCTATTTGCCTTGTTTC CAC – 3’ |
Integrated DNA Technologies | n/a | Vmn2r13 |
5’ – AGGAGATTTTACCAACCAGATTC CAG – 3’ |
Integrated DNA Technologies | n/a | |
5’ – CTCTAAGAACAGCAGTAAAATGG ATCT – 3’ |
Integrated DNA Technologies | n/a | Vmn2r89 |
5’ – ATGGGAATGACCAACTTAGGTGC A – 3’ |
Integrated DNA Technologies | n/a | |
5’ – ATCCCATGGCTGAGAACATGTGC TTCTGGAG – 3’ |
Integrated DNA Technologies | n/a | Vmn2r118 |
5’ – ATCCTCGAGTCAGTCTGCATAAG CCAGATATGTCAC – 3’ |
Integrated DNA Technologies | n/a | |
5’ – ATCGGATCCGCTGATTTTATTTCT CCCAGATGCTTTTGG – 3’ |
Integrated DNA Technologies | n/a | Vmn2r116 |
5’ – ATCCTCGAGTCATGGTTCTTCAT AGCTGAGAAATACAAC – 3’ |
Integrated DNA Technologies | n/a | |
5’ – TGGGTGTCTTCTTTCTCCTCAA GA – 3’ |
Integrated DNA Technologies | n/a | Vmn2r28 |
5’ – GGTGACCCATATTCTCTGTATAA CTGT – 3’ |
Integrated DNA Technologies | n/a | |
5’ – GATGTTCATTTTCATGAGAGTCT TCC – 3’ |
Integrated DNA Technologies | n/a | Vmn2r41 |
5’ – CATTTGTGGATGACATCACAATT TGG – 3’ |
Integrated DNA Technologies | n/a | |
5’ – TTTATGGCAAATTTCACTGATCCC G – 3’ |
Integrated DNA Technologies | n/a | Vmn2r46 |
5’ – AGTGGGTCTTTCTTAGAAAGGAG TG – 3’ |
Integrated DNA Technologies | n/a | |
5’ – ACATGAACCAGAATTTGAAGCAG GC – 3’ |
Integrated DNA Technologies | n/a | Vmn2r69 |
5’ – GCCAAGAAAGCTACAGTGAAAC C – 3’ |
Integrated DNA Technologies | n/a | |
5’ – AGGTGAAGAAATGGTATTCTTCC AG – 3’ |
Integrated DNA Technologies | n/a | Vmn2r58 |
ACTGTGGCCTTGAATGCAATAACT – 3’ | Integrated DNA Technologies | n/a | |
5’ – TTCCTAAAGAACACCCTACTGA AGCATCG – 3’ |
Integrated DNA Technologies | n/a | Vmn2r90 |
5’ – CATATTCCACAGAAGAGAAGT TGGAC – 3’ |
Integrated DNA Technologies | n/a | |
5’ – TTGAGGTGAGAGTCAACAGT TTAGAC – 3’ |
Integrated DNA Technologies | n/a | Vmn2r107 |
5’ – CCCTTGTTGCACAAAATGAT GATGTGA – 3’ |
Integrated DNA Technologies | n/a | |
5’ – ATCCCATGGAGTCAGAGTAT CTACTACACCATGATGG – 3’ |
Integrated DNA Technologies | n/a | Vmn2r83 |
5’ – ATCCTCGAGTCAATCATTAT AGTCCAGAAAGGTGACAG – 3’ |
Integrated DNA Technologies | n/a | |
Recombinant DNA | |||
pGEM-T-Easy vector | Promega | A1360 | reccommended PCR cloning vector |
Other materials | |||
1mL syringes | Fisher Scientific | 14-829-10F | n/a |
Conical tubes (15 mL and 50 mL) | Fisher Scientific | 14-432-22, 14-959-49B | n/a |
Coplin jars | Fisher Scientific | 12-567-099, 07-200-81 | n/a |
Cryostat | Leica Biosystems | CMS 1850 | n/a |
Dissecting tools and forceps | Roboz | RS-6802, RS-8124, RS-7110, RS-5111 | n/a |
Dry bath | n/a | n/a | n/a |
Electrophoresis equipment | Fisher Scientific | 09-528-110B | n/a |
Fine point paintbrushes | Winsor & Newton | 10269097 | n/a |
Fluorescence or confocal microscope | Leica Microsystems | TCS SP5II | n/a |
Heated plate | Fisher Scientific | HP88850200 | n/a |
Humidified chamber (if used at higher temperatures, it will need to be sealed inside a plastic Tupperware container) | Thermo Fisher Scientific | 22-045-034 | n/a |
Lint-free laboratory Kimwipes | Kimberly-Clark | 34120 | refered to as lint-free laboratory tissue paper |
Microcentrifuge | Eppendorf | 5401000013 | n/a |
Mouse cages | InnoVive | M-BTM, MVX1 | n/a |
PCR Thermocycler | Thermo Fisher Scientific | 4375786 | n/a |
Pipette p1000, p200, and p20 disposable tips | Fisher Scientific | 02-707-408, 02-707-411, 02-707-438 | n/a |
Plastic histology embedding mold | Thermo Fisher Scientific | 22-19 | n/a |
Qubit 4 Fluorometer | Thermo Fisher Scientific | Q33238 | refered to as highly sensitive fluorometric method |
Razor blades or scalpels | Fisher Scientific | 12-640 | n/a |
RNA tapestation or BioAnalyzer | Agilent | 4200 TapeStation System or 2100 Bioanalyzer Instrument | n/a |
RNase-free glass or plastic graduated cylinders and beakers | Fisher Scientific | 10-462-833, 02-555-25B, 02-555-25D | n/a |
Stereomicroscope | Leica Microsystems | M80 | n/a |
SuperFrost Plus microscope slides | Thermo Fisher Scientific | 12-550-15 | referred to as positively charged microscope slides |
Parafilm | Bemis Company | PM999 | refered to as thermoplastic laboratory film |
Water bath | Thermo Fisher Scientific | TSCIR19 | n/a |
.